MXManlu Xiao

Manlu Xiao

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Manlu Xiao has a total of 28 co-authors. Here are the top co-authors by number of shared publications:

  • Jia Wen

    Department of Nephrology, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China

    2 shared publications
  • Zhilian Li

    Department of Nephrology, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China

    2 shared publications
  • Cailin Su

    Department of Endocrinology and Metabolism, Nanfang Hospital Southern Medical University Guangzhou China

    1 shared publication
  • Danna Chen

    Medical Research Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China

    1 shared publication
  • Dantong Li

    Department of Nephrology, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, Guangdong, 510080, China

    1 shared publication
  • Dinglin Liu

    Department of Nephrology, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China

    1 shared publication

Latest Publications

  • Open Access

    Single-cell Stereo-seq reveals regulatory mechanisms driving regeneration of injured proximal tubules during AKI

    by Wenbiao Wang, Xingchen Zhao, Yubing Chen, Jia Wen, Manlu Xiao, Zepeng Guo, Danna Chen, Dinglin Liu, Rui Zhang, Hanbo Li, et al.

    Acute kidney injury (AKI) is a clinical syndrome characterized by a rapid decline in renal function. Proximal tubule (PT) cells play a central role in AKI. However, the specific populations and states of PT that facilitate repair remain poorly understood. Here, we combine spatial enhanced resolution omics sequencing with single-nucleus RNA sequencing to profile kidney transcriptomes during AKI. We identify an ischemia-reperfusion injury-induced PT subtype, termed proliferative PT, that likely initiates renal regeneration and exhibits a gene expression enriched in mitosis and metabolic processes. Acsm2 is expressed in proliferative PT and is associated with cell cycle progression. Functional studies reveal the protective role of Acsm2 via deficiency and overexpressing mice. Finally, we identify a subcluster of Fibroblast (FIB_C2) that participates in PT repair through cell-cell communication with proliferative PT. Our study provides an integrated high-resolution spatiotemporal atlas of AKI and reveals the important role of Acsm2 in kidney regeneration.


  • Proteomic insights into the dynamic inflammatory and metabolic networks of renal ischemia–reperfusion injury

    by Jieyi Luo, Jintao He, Zhiyong Xie, Yingwen Chen, Huaban Liang, Xingchen Zhao, Zhilian Li, Dantong Li, Jia Wen, Manlu Xiao, et al.


  • Open Access

    Polo‐like kinase2 regulates renal tubulointerstitial fibrosis via notch signaling pathway in diabetic kidney disease

    by Jiayi Luo, Haibin Xu, Cailin Su, Wenhui Dong, Manlu Xiao, Nan Xiao, Yijie Jia, Yaoming Xue

    Renal tubulointerstitial fibrosis is considered as an important pathological feature of diabetic kidney disease (DKD). However, the underlying mechanism remains unclear. Polo‐like kinase2 (PLK2) is a known player in the regulation of organ fibrosis. Herein, we investigated the expression and function of PLK2 in renal tubular epithelial cells in DKD. Data from the GSE30529 datasets were subjected to analyze the differentially expressed genes (DEGs) in non‐diabetic and diabetic renal tubule samples. Molecular docking analysis and Co‐IP assay were performed to investigate the interaction between PLK2 and NOTCH1. Immunohistochemistry, immunofluorescent staining, qRT‐PCR, and western blot were performed. Our research revealed an increased expression of PLK2 in both DKD mouse kidney tissues and HK‐2 cells stimulated by high glucose (HG). Silencing PLK2 remarkably reduced the expression of the renal fibrosis‐related markers fibronectin (FN), connective tissue growth factor (CTGF) and alpha smooth muscle actin(αSMA). Furthermore, we verified the interaction between PLK2 and NOTCH1. Silencing PLK2 significantly inhibited the activation of the Notch signaling pathway, and concurrently overexpressing HES1 rescued the downregulation of FN, CTGF, and αSMA induced by transfecting si‐PLK2. Finally, we found that treatment with DAPT suppressed the activation of the Notch signaling pathway and reversed the progression of renal fibrosis caused by HG. This study demonstrates that PLK2 mediates renal tubulointerstitial fibrosis in DKD by activating the Notch signaling pathway, suggesting that PLK2 may be a potential therapeutic target for DKD.